Dr. Jeffrey Weber on Potential Breakthrough "Cures" in Melanoma

March 15, 2016
Jeffrey Weber, MD, PhD

Weber says these treatments, such as ipilimumab plus nivolumab, or dabrafenib and trametinib, have seen marked improvements since 2009, and continue to become more important in the treatment paradigm of melanoma.

Jeffrey Weber, MD, PhD, NYU Langone Medical Center's Laura and Isaac Perlmutter Cancer Center, discusses immunotherapies and BRAK/MEK inhibitors potentially being able to cure patients with melanoma. Weber says these treatments, such as ipilimumab plus nivolumab, or dabrafenib and trametinib, have seen marked improvements since 2009, and continue to become more important in the treatment paradigm of melanoma.